Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga March 26, 2015 at 08:19 AM EDT Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares gained 27.65% to $7.34 in the pre-market trading session on positive Phase 2 liver ... Read More >> Related Stocks: Accenture Plc ConAgra Foods Conatus Pharmaceutic Five Below Inc Red Hat